Planet 13 Holdings (PLNH) Receivables - Other (2025 - 2026)
Planet 13 Holdings' (PLNH) quarterly Receivables - Other came in at $1.6 million in Q1 2026, down 57.97% on a QoQ basis from $3.8 million in Q4 2025.
Planet 13 Holdings (PLNH) Receivables - Other (2025 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has 2 years of Receivables - Other data on file, last reported at $1.6 million in Q1 2026.
- On a quarterly basis, Receivables - Other changed N/A year-over-year to $1.6 million in Q1 2026; TTM through Mar 2026 was $1.6 million, a N/A change from a year earlier, with the FY2025 full-year figure at $3.8 million, changed N/A from the prior year.
- Receivables - Other for Q1 2026 stood at $1.6 million, down from $3.8 million in the prior quarter.
- Over the last five years, Receivables - Other for PLNH reached as high as $3.8 million in Q4 2025 and fell as low as $1.6 million in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Planet 13 Holdings | 39.35 Mn | 23.09 Mn | 9.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.58 Mn |
| Mar 31, 2026 | 1.58 Mn |
| Dec 31, 2025 | 3.75 Mn |
| Dec 31, 2025 | 3.75 Mn |